SCHEMBL8720757

SCHEMBL8720757

O=C(Nc1ccc2scc(C3=CCN4CCCCC4CC3)c2c1)c1cc(F)cc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 1/20 0.39
TP53 P04637 2/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
HSD11B1 P28845 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35
CSF1R P07333 1/20 0.34
HRH3 Q9Y5N1 2/20 0.33
MCHR1 Q99705 2/20 0.33
IDO1 P14902 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8724021 0.90 HTR1F (0.40) TP53MAPTRAB9ANPC1HRH3
SCHEMBL8721285 0.88 KCNQ3 (0.40) ACKR3TP53MAPTLMNARAB9A
SCHEMBL8720711 0.86 TP53 (0.44) TP53MAPTLMNARAB9ANPC1
SCHEMBL8720679 0.85 MAPK14 (0.38) ACKR3TP53MAPTRAB9ANPC1
SCHEMBL8725926 0.83 TDP1 (0.41) TP53MAPTLMNARAB9ANPC1
SCHEMBL8706037 0.83 ALDH1A1 (0.42) ACKR3TP53MAPTLMNARAB9A
SCHEMBL8721911 0.81 KMT2A (0.43) ACKR3TP53MAPTLMNARAB9A
SCHEMBL8724051 0.81 AKR1C3 (0.38) MAPTRAB9ANPC1HRH3CYP3A4
SCHEMBL8723604 0.81 TDP1 (0.39) ACKR3TP53MAPTLMNARAB9A
SCHEMBL8720781 0.80 MAPT (0.45) TP53MAPTLMNARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073845-A1 METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS VALORISATION HSJ, LIMITED PARTNERSHIP (CA) 2024-04-11 WO disclosed
EP-0875513-A1 Substituted heteroaromatic 5-HT 1F agonists ELI LILLY AND COMPANY (US) 1998-11-04 EP disclosed